fluorodopa F 18: Clinical Trials

7 trials of fluorodopa F 18, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 2 terminated. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Recruiting 3, Completed 2, Terminated 2

Follow fluorodopa F 18: new trials by email Literature Review of fluorodopa F 18 trials Research Report on fluorodopa F 18

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[18F]F-DOPA Imaging in Patients With Autonomic Failure
[18F]FDOPA, Carbidopa 200mg oral dose, Entacapone 400mg oral dose - Autonomic Failure, Pure Autonomic Failure
Phase 1RecruitingDaniel Claassen402020-02-042026-03-16
PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects
18F-FDOPA, 11C-DASB - Depression, HIV Infections
Phase 1CompletedNational Institutes of Health Clinical Center (CC)462018-11-202023-03-21
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia
Ralmitaront, Radiolabeled PET tracer [18F]-DOPA, Placebo - Schizophrenia
Phase 1CompletedHoffmann-La Roche352018-11-072025-03-17
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine, PET/MRI, Surgical resection (standard of care) - Glioma, Malignant Glioma
Phase 1TerminatedWashington University School of Medicine112015-03-012016-11-30
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
FDOPA PET - Glioma, Glioblastoma
Phase 1TerminatedThe Methodist Hospital Research Institute312014-05-012018-08-17
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Fluorodopa F 18 - Congenital Hyperinsulinism, Insulinoma
Phase 1RecruitingCook Children's Health Care System2502013-10-092024-07-16
Diagnosis of Pheochromocytoma
([18F]-DOPA), ([18F]-6F-DA) - Pheochromocytoma, Endocrine Disease
Phase 1RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)30002000-03-222026-10-08

Conditions studied

Glioma (2)  ·  AIDS Dementia Complex (1)  ·  Congenital Hyperinsulinism (1)  ·  Depression (1)  ·  Endocrine System Diseases (1)  ·  Glioblastoma (1)  ·  HIV Infections (1)  ·  Hyperinsulinism (1)  ·  Hypoglycemia (1)  ·  Insulinoma (1)  ·  Lewy Body Disease (1)  ·  Multiple System Atrophy (1)  ·  Parkinson Disease (1)  ·  Pheochromocytoma (1)  ·  Pure Autonomic Failure (1)

Sponsors

Cook Children's Health Care System (1)  ·  Daniel Claassen (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Hoffmann-La Roche (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  The Methodist Hospital Research Institute (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)

Top investigators

Catherine M Gordon, M.D. (1)  ·  Daniel Lee, MD, PhD (1)  ·  Dima A Hammoud, M.D. (1)  ·  Paul Thornton, MD (1)  ·  Tammie Benzinger, M.D., Ph.D. (1)

Results publications

PMID 29534198, PMID 31057686, PMID 31231443, PMID 34431366